Behçet's Disease-Do Microbiomes and Genetics Collaborate in Pathogenesis?

Front Immunol. 2021 May 21:12:648341. doi: 10.3389/fimmu.2021.648341. eCollection 2021.

Abstract

Behçet's disease (BD) is a multisystem autoinflammatory condition characterized by mucosal ulceration, breakdown of immune privilege sites and vasculitis. A genetic basis for BD has been described in genome-wide and validation studies. Similarly, dysbiosis of oral and gut microbiomes have been associated with BD. This review will describe links between genetic polymorphisms in genes encoding molecules involved in gut biology and changes seen in microbiome studies. A potential decrease in bacterial species producing short chain fatty acids linked to mutations in genes involved in their production suggests a potential therapy for BD.

Keywords: Behçet’s disease; butyrate; genetic polymorphism; gut; microbiome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bacteria / metabolism
  • Behcet Syndrome / genetics*
  • Behcet Syndrome / immunology
  • Behcet Syndrome / microbiology*
  • Butyrates / metabolism
  • Butyrates / therapeutic use
  • Colitis / drug therapy
  • Colitis / immunology
  • Colitis / microbiology
  • Disease Models, Animal
  • Dysbiosis / genetics*
  • Dysbiosis / immunology
  • Dysbiosis / metabolism
  • Fatty Acids, Volatile / metabolism
  • Gastrointestinal Microbiome / genetics*
  • Genetic Predisposition to Disease*
  • Humans
  • Mice
  • Mutation
  • Polymorphism, Single Nucleotide*
  • Treatment Outcome

Substances

  • Butyrates
  • Fatty Acids, Volatile